1. Feoktistov A.S., Gavrilin M.A., Karagodin V.P., Bobryshev Yu.V., Orekhov A.N. Promising therapeutic approaches to inhibition of atherogenic modification (desialic) LDL. Patogenez. 2013; 11 (2): 46—50 (in Russian)
2. Aksenov D.V., Medvedeva L.A., Skalbe T.A., Sobenin I.A., Tertov V.V., Gabbasov Z.A. et al. Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro. Arh. Fiziol. Biohim. 2008; 114 (5): 349—56 (in Russian)
3. Borodachev E.N., Sobenin I.A., Karagodin V.P., Bobryshev Yu.V., Orekhov A.N. Multiple modification of low density lipoproteins in diabetes mellitus. Patogenez. 2013, 11 (4): 16—21. (in Russian)
4. Orekhov A.N. Mechanisms of atherogenesis and development of antiatherosclerotic therapy. Curr. Pharm. 2015; 21 (9): 1103—6.
5. Mel'nichenko А.А., Orekhova V.А., Sobenin I.A., Karagodin V.P., Orekhov A.N. The development of cellular models to assess the reverse cholesterol transport. Patogenez. 2013; 11 (4): 39—48 (in Russian)